Pharma Foods International Co., Ltd.

TSE:2929 Stock Report

Market Cap: JP¥27.8b

Pharma Foods International Management

Management criteria checks 1/4

Pharma Foods International's CEO is Yongsook Kim, appointed in Nov 1999, has a tenure of 25.17 years. directly owns 13.11% of the company’s shares, worth ¥3.65B. The average tenure of the management team and the board of directors is 1.3 years and 7.8 years respectively.

Key information

Yongsook Kim

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure25.2yrs
CEO ownership13.1%
Management average tenure1.3yrs
Board average tenure7.8yrs

Recent management updates

Recent updates

Pharma Foods International Co., Ltd.'s (TSE:2929) Prospects Need A Boost To Lift Shares

Oct 31
Pharma Foods International Co., Ltd.'s (TSE:2929) Prospects Need A Boost To Lift Shares

We Think Pharma Foods International's (TSE:2929) Solid Earnings Are Understated

Sep 22
We Think Pharma Foods International's (TSE:2929) Solid Earnings Are Understated

Is Pharma Foods International (TSE:2929) Using Too Much Debt?

Jul 23
Is Pharma Foods International (TSE:2929) Using Too Much Debt?

We Like Pharma Foods International's (TSE:2929) Earnings For More Than Just Statutory Profit

Mar 23
We Like Pharma Foods International's (TSE:2929) Earnings For More Than Just Statutory Profit

CEO

Yongsook Kim (77 yo)

25.2yrs

Tenure

Dr. Mu Jo Kim, also known as Yongsook, is the Chief Executive Officer of Pharma Foods International Co., Ltd. He has been the President of Pharma Foods International Co., Ltd. since November 1999 and serve...

Leadership Team

NamePositionTenureCompensationOwnership
Mu Jo Kim
CEO, President & Representative Director25.2yrsno data13.11%
¥ 3.6b
Yasunori Inoue
GM of Sales & Global Business Divisionless than a yearno data0.088%
¥ 24.4m
Kazuyuki Masuda
Senior MD8.4yrsno data2.55%
¥ 710.3m
Yong-il Kim
Director of Research & Development and Director1.3yrsno datano data
Hirotaka Higashiyama
Director of Management Department & Director1.3yrsno data0.0092%
¥ 2.6m

1.3yrs

Average Tenure

48yo

Average Age

Experienced Management: 2929's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Mu Jo Kim
CEO, President & Representative Directorno datano data13.11%
¥ 3.6b
Yasunori Inoue
GM of Sales & Global Business Division5.3yrsno data0.088%
¥ 24.4m
Kazuyuki Masuda
Senior MD16.3yrsno data2.55%
¥ 710.3m
Yong-il Kim
Director of Research & Development and Director1.3yrsno datano data
Hirotaka Higashiyama
Director of Management Department & Director1.3yrsno data0.0092%
¥ 2.6m
Nobuo Hatta
External Auditor11.3yrsno data0.026%
¥ 7.2m
Shinya Samura
Outside Independent Director9.3yrsno data0.068%
¥ 18.8m
Takashi Iino
Head of Audit & Supervisory Board15.3yrsno data0.072%
¥ 20.0m
Shinya Tsujimoto
External Auditor14.3yrsno data0.037%
¥ 10.4m
Tetsuro Yamane
Outside Independent Director6.3yrsno datano data
Taro Ueda
Outside Independent Director3.3yrsno datano data
Yukako Hayashi
Independent Outside Directorno datano datano data

7.8yrs

Average Tenure

66yo

Average Age

Experienced Board: 2929's board of directors are considered experienced (7.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 02:30
End of Day Share Price 2025/01/10 00:00
Earnings2024/10/31
Annual Earnings2024/07/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Pharma Foods International Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kiyokazu YamazakiIchiyoshi Research Institute Inc.